SCHEMBL24767935

SCHEMBL24767935

c1ccc(-n2c3ncccc3c3c4c(c5ccccc5c32)c2ccccc2n4-c2ccc3c4c(cccc24)-c2ccccc2-3)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 2/20 0.36
TSHR P16473 2/20 0.36
MEN1 O00255 2/20 0.36
CASP1 P29466 2/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
HBB P68871 1/20 0.36
FEN1 P39748 1/20 0.36
CYP2C19 P33261 1/20 0.36
PDE4A P27815 7/20 0.35
PDE4B Q07343 6/20 0.35
PDE4C Q08493 6/20 0.35
PDE4D Q08499 6/20 0.35
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
USP2 O75604 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21676159 0.87 L3MBTL1 (0.41) KDM4EALDH1A1TSHRMEN1CASP1
SCHEMBL21676160 0.81 PDE6D (0.35) KDM4EALDH1A1TSHRMEN1CASP1
SCHEMBL17341526 0.79 KEAP1 (0.41) KDM4EALDH1A1TSHRMEN1CASP1
SCHEMBL17349104 0.79 KDM4E (0.44) KDM4EALDH1A1TSHRFEN1CYP2C19
SCHEMBL21676181 0.79 ALDH1A1 (0.35) KDM4EALDH1A1TSHRMEN1CASP1
SCHEMBL24768874 0.79 PDE4A (0.35) KDM4EALDH1A1TSHRFEN1CYP2C19
SCHEMBL21676161 0.78 L3MBTL1 (0.41) KDM4EALDH1A1TSHRMEN1CASP1
SCHEMBL17349052 0.77 KDM4E (0.47) KDM4EALDH1A1TSHRFEN1CYP2C19
SCHEMBL18958261 0.77 KDM4E (0.44) KDM4EALDH1A1TSHRFEN1CYP2C19
SCHEMBL19997995 0.76 KDM4E (0.42) KDM4EALDH1A1TSHRMEN1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220251077-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220251077-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME SLCO4C1, SLCO2A1, SLCO2B1 KDM4E 2549/4885ALDH1A1 404/4885TSHR 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.